Patient Characteristics
| . | MEL100 . | MP . | . |
|---|---|---|---|
| No. of patients | 71 | 71 | |
| Age | |||
| <60 yrs | 18 | 18 | |
| >60 yrs | 53 | 53 | |
| β2-microglobulin | Matching criteria | ||
| <3 mg/L | 19 | 19 | |
| >3 mg/L | 52 | 52 | |
| % of patients | |||
| Stage at diagnosis | |||
| II | 25 | 28 | |
| III | 75 | 72 | |
| Isotype | |||
| IgG | 58 | 68 | |
| IgA | 21 | 22 | |
| Bence Jones protein | 21 | 10 | |
| Creatinine >2 mg/dL | 6 | 11 | |
| Hemoglobin <10 g/dL | 40 | 47 | |
| Labeling index >1.2% | 28 | 30 | |
| Bone marrow plasmocytosis >30% | 62 | 64 | |
| Performance status >3 | 54 | 56 |
| . | MEL100 . | MP . | . |
|---|---|---|---|
| No. of patients | 71 | 71 | |
| Age | |||
| <60 yrs | 18 | 18 | |
| >60 yrs | 53 | 53 | |
| β2-microglobulin | Matching criteria | ||
| <3 mg/L | 19 | 19 | |
| >3 mg/L | 52 | 52 | |
| % of patients | |||
| Stage at diagnosis | |||
| II | 25 | 28 | |
| III | 75 | 72 | |
| Isotype | |||
| IgG | 58 | 68 | |
| IgA | 21 | 22 | |
| Bence Jones protein | 21 | 10 | |
| Creatinine >2 mg/dL | 6 | 11 | |
| Hemoglobin <10 g/dL | 40 | 47 | |
| Labeling index >1.2% | 28 | 30 | |
| Bone marrow plasmocytosis >30% | 62 | 64 | |
| Performance status >3 | 54 | 56 |